A detailed history of Harvest Investment Services, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Harvest Investment Services, LLC holds 21,934 shares of HROW stock, worth $763,961. This represents 0.18% of its overall portfolio holdings.

Number of Shares
21,934
Previous 23,048 4.83%
Holding current value
$763,961
Previous $773,000 24.58%
% of portfolio
0.18%
Previous 0.2%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

SELL
$22.22 - $36.67 $24,753 - $40,850
-1,114 Reduced 4.83%
21,934 $583,000
Q4 2024

Feb 14, 2025

BUY
$33.39 - $57.5 $769,572 - $1.33 Million
23,048 New
23,048 $773,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $943M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Harvest Investment Services, LLC Portfolio

Follow Harvest Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Investment Services, LLC with notifications on news.